Etiqueta: stem cell research
-
FDA Grants Clearance for the First Clinical Study With Placental Stem Cells
Celgene Cellular Therapeutics receives FDA authorization to commence the first clinical trials ever to be conducted in the U.S. with adult stem cells derived from placental blood.
-
Opexa to Present Data on its Cellular Therapies for Autoimmune Diseases
Opexa Therapeutics is scheduled to present an overview of its T-cell and adult stem cell therapies for autoimmune diseases at an annual health care conference.
-
Genzyme and Osiris Form Adult Stem Cell Mega-Partnership
In one of the largest business arrangements ever made, Osiris and Genzyme agree upon a major adult stem cell collaboration.
-
The Potentiation of Mesenchymal Stem Cells Improves Cardiac Regeneration
Scientists increase the efficacy of mesenchymal stem cells through a process of molecular «supercharging» for the therapeutic regeneration of heart tissue following myocardial infarction.
-
Neuralstem Licenses Technology for Spinal Cord Treatment
The stem cell company Neuralstem, Inc., announces the licensing of patents for the delivery of targeted spinal cord therapeutics.
-
Pfizer Expands Into Stem Cell Research
Lured by the promise of financial profit, the pharmaceutical giant Pfizer joins the stem cell community.
-
Pluristem’s Adult Stem Cell Product Shows Promise as Therapy for Multiple Sclerosis
The biotech company Pluristem Therapeutics has developed an adult stem cell product for the prevention of clinical symptoms of multiple sclerosis.
-
Two Leading Biotech Companies Collaborate on a Department of Defense Contract for Adult Stem Cell Applications in Warfare
In an effort to develop adult stem cell therapies that are specifically targeted to counteracting the biological dangers of nuclear warfare, the U.S. Deparment of Defense has awarded a $224.7 million contract to an Osiris-Genzyme partnership.
-
FDA Authorizes Device for Bone Marrow Stem Cell Preparation
A leading manufacturer of medical machinery that is used in the processing of stem cells has received FDA approval for the marketing of its newest device.
-
Large-Scale Adult Stem Cell Trials Planned for Children With Sickle Cell Anemia
Researchers at the Washington University School of Medicine in St. Louis lead a nationwide, multicenter clinical trial to study the efficacy of adult stem cell therapy in the treatment of children with sickle cell anemia.